SomaLogic, Inc.

SomaLogic, Inc. (Nasdaq: SLGC) is a Boulder, Colorado-based proteomics and life sciences company that completed its business combination with CM Life Sciences III, Inc. in September 2021, with the transaction sponsored by CM Life Sciences. The company, which develops SomaScan, a proprietary protein measurement platform used in drug discovery and clinical diagnostics, began trading publicly under the SLGC ticker following that de-SPAC transaction. An 8-K filed January 5, 2024 relates to the company's pending merger with Standard BioTools Inc., a combination announced in late 2023 that moved SomaLogic toward an integrated multi-omics commercial structure. Sign up at SpacDesk for full filing history, sponsor profiles, and deal analytics on SLGC and hundreds of other de-SPAC companies.